{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:03Z","timestamp":1791414123964,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"EDCTP","doi-asserted-by":"crossref","award":["RIA2019AMR-2647"],"award-info":[{"award-number":["RIA2019AMR-2647"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09568-9","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:15:25Z","timestamp":1772158525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbe"],"prefix":"10.1186","volume":"27","author":[{"given":"D.","family":"Mudzengi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mashatole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Adrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ngwanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mdluli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Boniface","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rassool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Matome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Paramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fasanmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Khosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mokaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mofokeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lalashowi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fumane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Maphossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Brumskine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Venter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mapamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kooverjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Botha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Foraida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin Mark","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Sabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ntinginya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"panTB-HM Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcina","family":"Zitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezelda","family":"Macuiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catildo","family":"Cubai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"Boque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ducilia","family":"Matimbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supinho","family":"Chibandje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ligeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlandy","family":"Basson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rachow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Nyanhongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"de Klerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engela","family":"du Plooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kgothatso Precious","family":"Tau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mokhoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabika Christian","family":"Kasongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lethabo Colleen","family":"Theko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Ruele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obakeng Peter","family":"Booi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mando Mmakhora","family":"Thaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seasebeng Pertunia","family":"Mothobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni Ni","family":"Sein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamogelo Fortunate","family":"Matlhase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshukutjoane Lebogang","family":"Maila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip Mafori","family":"Mphahlele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitekani Kgomotso","family":"Theko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshegofatso Magnus","family":"Ramatlhape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Neo","family":"Senne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nondzakazi","family":"Mnqonywa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rendani Helen","family":"Ngwagwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifiso Cornelius","family":"Shezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosisa Charity","family":"Mkhize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mmarona Elizabeth","family":"Lekalakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal Onkgopotse","family":"Molotsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabelo","family":"Letshwiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Kgothatso","family":"Masilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyabonga","family":"Nhlapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaszmin Neo","family":"Rakuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketlhomogetswe Magdeline","family":"Molatlhegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malebogo Matsopyane","family":"Mampane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluwani Adolf","family":"Thovhakale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Alida","family":"Baumgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheily Christina","family":"Lekotloane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karabo","family":"Molefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primrose Ketshepile Ketshepile","family":"Motswenyane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mmalebone Realeboga","family":"Ntantiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesego","family":"Letlole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siphiwe","family":"Mabote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refilwe Gontse","family":"Powane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ntombikaise","family":"Tyobeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Bhoola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tebatso","family":"Matsepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nthati","family":"Nke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themba","family":"Phakathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zithelo","family":"Zikalala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvester","family":"Magwasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Spies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuyokazi","family":"Jezile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coreen","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"9568_CR1","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global tuberculosis report. Geneva: WHO; 2023."},{"issue":"5","key":"9568_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.rppneu.2011.06.010","volume":"17","author":"FC Di Naso","year":"2011","unstructured":"Di Naso FC, Pereira JS, Schuh SJ, Unis G. [Functional evaluation in patients with pulmonary tuberculosis sequelae]. Rev Port Pneumol. 2011;17(5):216\u201321.","journal-title":"Rev Port Pneumol"},{"key":"9568_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00026-2017","author":"AL Byrne","year":"2017","unstructured":"Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, et al. Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis. ERJ Open Res. 2017. https:\/\/doi.org\/10.1183\/23120541.00026-2017.","journal-title":"ERJ Open Res"},{"key":"9568_CR4","unstructured":"WHO. Target regimen profiles for TB treatment. Geneva: WHO; 2016. Report No.: WHO\/HTM\/TB\/2016.16.\u00a0https:\/\/www.who.int\/publications\/i\/item\/9789241511339."},{"issue":"8","key":"9568_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.2471\/BLT.24.291881","volume":"102","author":"C Lienhardt","year":"2024","unstructured":"Lienhardt C, Dooley KE, Nahid P, Wells C, Ryckman TS, Kendall EA, et al. Target regimen profiles for tuberculosis treatment. Bull World Health Organ. 2024;102(8):600\u20137.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"9568_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1164\/rccm.200904-0611OC","volume":"180","author":"KN Williams","year":"2009","unstructured":"Williams KN, Brickner SJ, Stover CK, Zhu T, Ogden A, Tasneen R, et al. Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis. Am J Respir Crit Care Med. 2009;180(4):371\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"9568_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1128\/AAC.01182-08","volume":"53","author":"KN Williams","year":"2009","unstructured":"Williams KN, Stover CK, Zhu T, Tasneen R, Tyagi S, Grosset JH, et al. <article-title update=\"added\">Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model. Antimicrob Agents Chemother. 2009;53(4):1314\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"9568_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030479","volume":"7","author":"RS Wallis","year":"2012","unstructured":"Wallis RS, Jakubiec W, Mitton-Fry M, Ladutko L, Campbell S, Paige D, et al. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide. PLoS One. 2012;7(1):e30479.","journal-title":"PLoS One"},{"issue":"4","key":"9568_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094462","volume":"9","author":"RS Wallis","year":"2014","unstructured":"Wallis RS, Dawson R, Friedrich SO, Venter A, Paige D, Zhu T, et al. Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis. PLoS One. 2014;9(4):e94462.","journal-title":"PLoS One"},{"issue":"2","key":"9568_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1128\/AAC.01179-10","volume":"55","author":"RS Wallis","year":"2011","unstructured":"Wallis RS, Jakubiec W, Kumar V, Bedarida G, Silvia A, Paige D, et al. Biomarker assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis. Antimicrob Agents Chemother. 2011;55(2):567\u201374.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"9568_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/655471","volume":"202","author":"RS Wallis","year":"2010","unstructured":"Wallis RS, Jakubiec W, Kumar V, Silvia AM, Paige D, Dimitrova D, et al. Pharmacokinetics and whole blood bactericidal activity against Mycobacterium tuberculosis of single ascending doses of PNU-100480 in healthy volunteers. J Infect Dis. 2010;202(5):745\u201351.","journal-title":"J Infect Dis"},{"key":"9568_CR12","unstructured":"Heinrich N, Manyama C, Ntinginya EN, Mpagama S, Liyoyo A, Mhimbira F, et al. PanACEA SUDOCU combination dose-finding trial shows sutezolid is a safe oxazolidinone. CROI; Feb 19, 2023; Seattle. Seattle2023.\u00a0https:\/\/www.croiconference.org\/abstract\/panacea-sudocu-combination-dose-finding-trial-shows-sutezolid-is-a-safe-oxazolidinone\/."},{"key":"9568_CR13","doi-asserted-by":"crossref","unstructured":"French G. Safety and tolerability of linezolid. J Antimicrob Chemother. 2003;51 Suppl 2:ii45\u201353.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/12730142\/.","DOI":"10.1093\/jac\/dkg253"},{"key":"9568_CR14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01181-2019","author":"O Olayanju","year":"2019","unstructured":"Olayanju O, Esmail A, Limberis J, Dheda K. A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug resistant tuberculosis. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.01181-2019.","journal-title":"Eur Respir J"},{"issue":"10","key":"9568_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, et al. Treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med. 2020;382(10):893\u2013902.","journal-title":"N Engl J Med"},{"issue":"7","key":"9568_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S1473-3099(20)30770-2","volume":"21","author":"KE Dooley","year":"2021","unstructured":"Dooley KE, Rosenkranz SL, Conradie F, Moran L, Hafner R, von Groote-Bidlingmaier F, et al. QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. Lancet Infect Dis. 2021;21(7):975\u201383.","journal-title":"Lancet Infect Dis"},{"issue":"24","key":"9568_CR17","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","volume":"319","author":"MJ Smilkstein","year":"1988","unstructured":"Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557\u201362.","journal-title":"N Engl J Med"},{"issue":"1","key":"9568_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-016-0872-7","volume":"16","author":"EP Amaral","year":"2016","unstructured":"Amaral EP, Concei\u00e7\u00e3o EL, Costa DL, Rocha MS, Marinho JM, Cordeiro-Santos M, et al. N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. BMC Microbiol. 2016;16(1):251.","journal-title":"BMC Microbiol"},{"issue":"10","key":"9568_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026254","volume":"6","author":"GS Palanisamy","year":"2011","unstructured":"Palanisamy GS, Kirk NM, Ackart DF, Shanley CA, Orme IM, Basaraba RJ. Evidence for oxidative stress and defective antioxidant response in guinea pigs with tuberculosis. PLoS One. 2011;6(10):e26254.","journal-title":"PLoS One"},{"issue":"9","key":"9568_CR20","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300332","volume":"3","author":"RS Wallis","year":"2024","unstructured":"Wallis RS, Sabi I, Lalashowi J, Bakuli A, Mapamba D, Olomi W, et al. Adjunctive N-acetylcysteine and lung function in pulmonary tuberculosis. NEJM Evidence. 2024;3(9):EVIDoa2300332.","journal-title":"NEJM Evidence"},{"issue":"3","key":"9568_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0954-6111(89)80031-9","volume":"83","author":"PA Willcox","year":"1989","unstructured":"Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med. 1989;83(3):195\u20138.","journal-title":"Respir Med"},{"key":"9568_CR22","doi-asserted-by":"crossref","unstructured":"Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, et al. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One. 2013;8(11):e80302.","DOI":"10.1371\/journal.pone.0080302"},{"issue":"8","key":"9568_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161176","volume":"11","author":"J Meghji","year":"2016","unstructured":"Meghji J, Simpson H, Squire SB, Mortimer K. A systematic review of the prevalence and pattern of imaging defined post-TB lung disease. PLoS One. 2016;11(8):e0161176.","journal-title":"PLoS One"},{"issue":"11","key":"9568_CR24","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/thx.2009.129999","volume":"65","author":"J Ross","year":"2010","unstructured":"Ross J, Ehrlich RI, Hnizdo E, White N, Churchyard GJ. Excess lung function decline in gold miners following pulmonary tuberculosis. Thorax. 2010;65(11):1010\u20135.","journal-title":"Thorax"},{"issue":"3","key":"9568_CR25","first-page":"369","volume":"8","author":"RI Ehrlich","year":"2004","unstructured":"Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, et al. Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis. 2004;8(3):369\u201376.","journal-title":"Int J Tuberc Lung Dis"},{"key":"9568_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijid.2014.12.016","volume":"32","author":"AL Byrne","year":"2015","unstructured":"Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015;32:138\u201346.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"9568_CR27","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1016\/S2214-109X(19)30070-1","volume":"7","author":"M Duong","year":"2019","unstructured":"Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, et al. Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study. Lancet Glob Health. 2019;7(5):e613\u201323.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"9568_CR28","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1378\/chest.118.3.656","volume":"118","author":"HJ Schunemann","year":"2000","unstructured":"Schunemann HJ, Dorn J, Grant BJ, Winkelstein W Jr., Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000;118(3):656\u201364.","journal-title":"Chest"},{"issue":"9","key":"9568_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","volume":"387","author":"F Conradie","year":"2022","unstructured":"Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, et al. Bedaquiline-Pretomanid-Linezolid regimens for drug-resistant tuberculosis. N Engl J Med. 2022;387(9):810\u201323.","journal-title":"N Engl J Med"},{"issue":"11","key":"9568_CR30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ebiom.2015.09.051","volume":"2","author":"T Song","year":"2015","unstructured":"Song T, Lee M, Jeon HS, Park Y, Dodd LE, Dartois V, et al. Linezolid trough concentrations correlate with mitochondrial toxicity-related adverse events in the treatment of chronic extensively drug-resistant tuberculosis. EBioMedicine. 2015;2(11):1627\u201333.","journal-title":"EBioMedicine"},{"issue":"10","key":"9568_CR31","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1086\/379012","volume":"37","author":"E Lee","year":"2003","unstructured":"Lee E, Burger S, Shah J, Melton C, Mullen M, Warren F, et al. Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis. 2003;37(10):1389\u201391.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"9568_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.sjopt.2018.10.010","volume":"33","author":"P Agashe","year":"2019","unstructured":"Agashe P, Doshi A. Linezolid induced optic neuropathy in a child treated for extensively drug resistant tuberculosis: a case report and review of literature. Saudi J Ophthalmol. 2019;33(2):188\u201391.","journal-title":"Saudi J Ophthalmol"},{"key":"9568_CR33","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.5114\/pjr.2020.93364","volume":"85","author":"T Kanda","year":"2020","unstructured":"Kanda T, Miyazaki A, Zeng F, Ueno Y, Sofue K, Maeda T, et al. Magnetic resonance imaging of intraocular optic nerve disorders: review article. Pol J Radiol. 2020;85:e67\u201381.","journal-title":"Pol J Radiol"},{"issue":"4","key":"9568_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","volume":"34","author":"J Sellner","year":"2010","unstructured":"Sellner J, Hemmer B, Muhlau M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun. 2010;34(4):371\u20139.","journal-title":"J Autoimmun"},{"issue":"5","key":"9568_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5588\/ijtldopen.25.0071","volume":"2","author":"NA Glover","year":"2025","unstructured":"Glover NA, Paramo L, Giangregorio S, Sukwana B, Koele SE, Charalambous S, et al. Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection. IJTLD Open. 2025;2(5):306\u20139.","journal-title":"IJTLD Open"},{"issue":"8","key":"9568_CR36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","volume":"9","author":"RS Wallis","year":"2021","unstructured":"Wallis RS, Ginindza S, Beattie T, Arjun N, Likoti M, Edward VA, et al. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med. 2021;9(8):897\u2013908.","journal-title":"Lancet Respir Med"},{"issue":"8","key":"9568_CR37","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70\u201388.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"9568_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125403","volume":"10","author":"RS Wallis","year":"2015","unstructured":"Wallis RS, Peppard T, Hermann D. Month 2 culture status and treatment duration as predictors of recurrence in pulmonary tuberculosis: model validation and update. PLoS One. 2015;10(4):e0125403.","journal-title":"PLoS One"},{"issue":"12","key":"9568_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5588\/ijtld.16.0231","volume":"20","author":"GR Davies","year":"2016","unstructured":"Davies GR, Wallis RS. Methods for selecting regimen duration to prevent relapse in drug-susceptible and drug-resistant TB. Int J Tuberc Lung Dis. 2016;20(12):13\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"18","key":"9568_CR40","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","volume":"384","author":"SE Dorman","year":"2021","unstructured":"Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, et al. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis. N Engl J Med. 2021;384(18):1705\u201318.","journal-title":"N Engl J Med"},{"key":"9568_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0597-3","volume":"14","author":"PP Phillips","year":"2016","unstructured":"Phillips PP, Dooley KE, Gillespie SH, Heinrich N, Stout JE, Nahid P, et al. A new trial design to accelerate tuberculosis drug development: the phase IIC selection trial with extended post-treatment follow-up (STEP). BMC Med. 2016;14:51.","journal-title":"BMC Med"},{"key":"9568_CR42","first-page":"839","volume":"81","author":"DW Alling","year":"1960","unstructured":"Alling DW, Bosworth EB. The after-history of pulmonary tuberculosis. VI. The first fifteen years following diagnosis. Am Rev Respir Dis. 1960;81:839\u201349.","journal-title":"Am Rev Respir Dis"},{"key":"9568_CR43","volume-title":"Diagnostic standards and classification of tuberculosis","author":"FH Heise","year":"1940","unstructured":"Heise FH, Kleinschmidt HE, Amberson JB, Gilbert GB, Kanable RH, Korns JH, et al. Diagnostic standards and classification of tuberculosis. New York: Standards CoD; 1940."},{"key":"9568_CR44","unstructured":"FDA. Priftin (rifapentine) tablets prescribing information. 2010.\u00a0https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/98\/21024.html."},{"issue":"1","key":"9568_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05491-3","volume":"22","author":"L Guglielmetti","year":"2021","unstructured":"Guglielmetti L, Ardizzoni E, Atger M, Baudin E, Berikova E, Bonnet M, et al. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial. Trials. 2021;22(1):651.","journal-title":"Trials"},{"issue":"9","key":"9568_CR46","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S2213-2600(25)00194-8","volume":"13","author":"L Guglielmetti","year":"2025","unstructured":"Guglielmetti L, Khan U, Velasquez GE, Gouillou M, Ali MH, Amjad S, et al. Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial. Lancet Respir Med. 2025;13(9):809\u201320.","journal-title":"Lancet Respir Med"},{"key":"9568_CR47","unstructured":"Sealed Envelope Ltd. Power calculator for binary outcome non-inferiority trials. 2012.\u00a0https:\/\/www.sealedenvelope.com\/power\/binary-noninferior\/."},{"issue":"4","key":"9568_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0197-2456(82)90024-1","volume":"3","author":"WC Blackwelder","year":"1982","unstructured":"Blackwelder WC. Proving the null hypothesis\" in clinical trials. Control Clin Trials. 1982;3(4):345\u201353.","journal-title":"Control Clin Trials"},{"issue":"10 Suppl 2","key":"9568_CR49","first-page":"S231","volume":"3","author":"W Fox","year":"1999","unstructured":"Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3(10 Suppl 2):S231\u201379.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"9568_CR50","first-page":"241","volume":"14","author":"AJ Nunn","year":"2010","unstructured":"Nunn AJ, Phillips PP, Mitchison DA. Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis. 2010;14(2):241\u20132.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09568-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09568-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09568-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:03:42Z","timestamp":1775225022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09568-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9568"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09568-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5943039\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and written informed consent were obtained according to ICH and GCP guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has any competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {7b}"}}],"article-number":"271"}}